The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 8,121,352 | 632,997 | SH | SOLE | 632,997 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 7,557,877 | 474,741 | SH | SOLE | 474,741 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 3,710,512 | 142,002 | SH | SOLE | 142,002 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 5,240,305 | 622,364 | SH | SOLE | 622,364 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 4,514,339 | 3,730,859 | SH | SOLE | 3,730,859 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 4,630,558 | 962,694 | SH | SOLE | 962,694 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 2,485,700 | 179,085 | SH | SOLE | 179,085 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 455,068 | 827,397 | SH | SOLE | 827,397 | 0 | 0 | ||
DENALI THERAPEUTICS INC | COM | 24823R105 | 124,561 | 4,479 | SH | SOLE | 4,479 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 2,045,119 | 811,555 | SH | SOLE | 811,555 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 6,215,597 | 140,054 | SH | SOLE | 140,054 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 4,044,443 | 326,428 | SH | SOLE | 326,428 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 3,048,501 | 896,618 | SH | SOLE | 896,618 | 0 | 0 | ||
MEDAVAIL HOLDINGS INC | COM | 58406B103 | 1,767,290 | 5,894,897 | SH | SOLE | 5,894,897 | 0 | 0 | ||
MORPHOSYS AG | SPONSORED ADS | 617760202 | 1,452,055 | 405,602 | SH | SOLE | 405,602 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 6,980,848 | 1,191,271 | SH | SOLE | 1,191,271 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 2,153,131 | 47,520 | SH | SOLE | 47,520 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 286,618 | 159,232 | SH | SOLE | 159,232 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 3,016,334 | 1,334,661 | SH | SOLE | 1,334,661 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 1,500,790 | 630,584 | SH | SOLE | 630,584 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 8,583,142 | 185,261 | SH | SOLE | 185,261 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 2,449,694 | 125,176 | SH | SOLE | 125,176 | 0 | 0 | ||
REPLIGEN CORP | COM | 759916109 | 2,062,196 | 12,180 | SH | SOLE | 12,180 | 0 | 0 | ||
RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 790,620 | 699,664 | SH | SOLE | 699,664 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 4,538,965 | 119,008 | SH | SOLE | 119,008 | 0 | 0 | ||
SANA BIOTECHNOLOGY INC | COM | 799566104 | 4,010,328 | 1,015,273 | SH | SOLE | 1,015,273 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 2,891,076 | 2,558,474 | SH | SOLE | 2,558,474 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 4,836,988 | 37,639 | SH | SOLE | 37,639 | 0 | 0 | ||
SCIENCE 37 HOLDINGS INC | COM | 808644108 | 159,602 | 384,397 | SH | SOLE | 384,397 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 3,117,567 | 868,403 | SH | SOLE | 868,403 | 0 | 0 |